Building an understanding of cystic fibrosis on the foundation of ABC transporter structures
- PMID: 18080175
- DOI: 10.1007/s10863-007-9117-7
Building an understanding of cystic fibrosis on the foundation of ABC transporter structures
Abstract
Cystic fibrosis (CF) is a fatal disease affecting the lungs and digestive system by impairment of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). While over 1000 mutations in CFTR have been associated with CF, the majority of cases are linked to the deletion of phenylalanine 508 (delta F508). F508 is located in the first nucleotide binding domain (NBD1) of CFTR. This mutation is sufficient to impair the trafficking of CFTR to the plasma membrane and, thus, its function. As an ABC transporter, recent structural data from the family provide a framework on which to consider the effect of the delta F508 mutation on CFTR. There are fifty-seven known structures of ABC transporters and domains thereof. Only six of these structures are of the intact transporters. In addition, modern bioinformatic tools provide a wealth of sequence and structural information on the family. We will review the structural information from the RCSB structure repository and sequence databases of the ABC transporters. The available structural information was used to construct a model for CFTR based on the ABC transporter homologue, Sav1866, and provide a context for understanding the molecular pathology of Cystic Fibrosis.
Similar articles
-
Modeling of nucleotide binding domains of ABC transporter proteins based on a F1-ATPase/recA topology: structural model of the nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator (CFTR).J Bioenerg Biomembr. 1997 Oct;29(5):503-24. doi: 10.1023/a:1022443209010. J Bioenerg Biomembr. 1997. PMID: 9511935
-
Substitution of Yor1p NBD1 residues improves the thermal stability of Human Cystic Fibrosis Transmembrane Conductance Regulator.Protein Eng Des Sel. 2017 Oct 1;30(10):729-741. doi: 10.1093/protein/gzx054. Protein Eng Des Sel. 2017. PMID: 29053845 Free PMC article.
-
Evolutionary and functional divergence between the cystic fibrosis transmembrane conductance regulator and related ATP-binding cassette transporters.Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18865-70. doi: 10.1073/pnas.0806306105. Epub 2008 Nov 19. Proc Natl Acad Sci U S A. 2008. PMID: 19020075 Free PMC article.
-
Cystic fibrosis: a disease of altered protein folding.J Bioenerg Biomembr. 1997 Oct;29(5):483-90. doi: 10.1023/a:1022439108101. J Bioenerg Biomembr. 1997. PMID: 9511933 Review.
-
Cystic fibrosis: recent structural insights.J Cyst Fibros. 2004 Aug;3 Suppl 2:91-4. doi: 10.1016/j.jcf.2004.05.020. J Cyst Fibros. 2004. PMID: 15463935 Review.
Cited by
-
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): CLOSED AND OPEN STATE CHANNEL MODELS.J Biol Chem. 2015 Sep 18;290(38):22891-906. doi: 10.1074/jbc.M115.665125. Epub 2015 Jul 30. J Biol Chem. 2015. PMID: 26229102 Free PMC article.
-
CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates.Nat Commun. 2020 Aug 26;11(1):4258. doi: 10.1038/s41467-020-18101-8. Nat Commun. 2020. PMID: 32848127 Free PMC article.
-
Complement yourself: Transcomplementation rescues partially folded mutant proteins.Biophys Rev. 2014 Mar 1;6(1):169-180. doi: 10.1007/s12551-014-0137-3. Biophys Rev. 2014. PMID: 24949105 Free PMC article.
-
Cystic fibrosis transmembrane regulator missing the first four transmembrane segments increases wild type and DeltaF508 processing.J Biol Chem. 2008 Aug 8;283(32):21926-33. doi: 10.1074/jbc.M709156200. Epub 2008 May 28. J Biol Chem. 2008. PMID: 18508776 Free PMC article.
-
Mechanisms for rescue of correctable folding defects in CFTRDelta F508.Mol Biol Cell. 2009 Sep;20(18):4059-69. doi: 10.1091/mbc.e08-09-0929. Epub 2009 Jul 22. Mol Biol Cell. 2009. PMID: 19625452 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials